Glixis Therapeutics Overview
- Founded
-
2012
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Glixis Therapeutics General Information
Description
Developer of novel therapies designed for autoimmune diseases. The company has engineered a pro-drug with a proprietary chemical structure that targets an underlying mechanism of progressive multiple sclerosis with secondary benefits to relapse and remit itself, enabling physicians to formulate a drug that can efficiently work for the smooth functioning between the brain and the body.
Contact Information
Website
www.glixis.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Primary Office
- 122 Calistoga Road
- Suite 346
- Santa Rosa, CA 95409
- United States
Glixis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 14-Jan-2021 | Completed | Out of Business | |||
| 2. Grant | 12-Jun-2014 | 00000 | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |